Type 2 Innate Lymphoid Cell in Cardiovascular Diseases: Complexities and Potentials

Abstract Innate lymphoid cells (ILCs) are a class of lymphocytes that do not express specific antigen recognition receptors, which play a significant role in various diseases due to their unique immunomodulatory functions. Among these, type 2 innate lymphoid cells (ILC2s) form a distinct subpopulati...

Full description

Saved in:
Bibliographic Details
Main Authors: Haibei Sun, Weizhuo Liu, Zelin Yu, Bin He
Format: Article
Language:English
Published: Springer 2025-02-01
Series:Intensive Care Research
Subjects:
Online Access:https://doi.org/10.1007/s44231-025-00078-x
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849390415216640000
author Haibei Sun
Weizhuo Liu
Zelin Yu
Bin He
author_facet Haibei Sun
Weizhuo Liu
Zelin Yu
Bin He
author_sort Haibei Sun
collection DOAJ
description Abstract Innate lymphoid cells (ILCs) are a class of lymphocytes that do not express specific antigen recognition receptors, which play a significant role in various diseases due to their unique immunomodulatory functions. Among these, type 2 innate lymphoid cells (ILC2s) form a distinct subpopulation and are recognized as key mediators in anti-infective and allergic responses. Cardiovascular diseases are a leading cause of intensive care unit admissions. Cardiovascular diseases, including myocardial infarction and heart failure, have a complex pathogenesis involving inflammation, tissue injury, and repair. Recent studies suggest that ILC2s are crucial in cardiovascular diseases by regulating inflammation, promoting tissue repair, and facilitating cardiac remodeling through the secretion of anti-inflammatory cytokines like IL-4, IL-5, and IL-13, etc. However, ILC2s have a complex role in cardiovascular health, potentially contributing to adverse cardiac remodeling and heart failure in certain contexts. Thus, the precise mechanisms by which ILC2s influence cardiovascular disease processes remain incompletely understood. This review summarizes recent advances in understanding ILC2 mechanisms in cardiovascular diseases and explores their potential as therapeutic targets, aiming to identify new treatment strategies.
format Article
id doaj-art-3dc85f80f52f447399d94ae7e7e29e1b
institution Kabale University
issn 2666-9862
language English
publishDate 2025-02-01
publisher Springer
record_format Article
series Intensive Care Research
spelling doaj-art-3dc85f80f52f447399d94ae7e7e29e1b2025-08-20T03:41:40ZengSpringerIntensive Care Research2666-98622025-02-014421022210.1007/s44231-025-00078-xType 2 Innate Lymphoid Cell in Cardiovascular Diseases: Complexities and PotentialsHaibei Sun0Weizhuo Liu1Zelin Yu2Bin He3Department of Critical Care Medicine and Emergency, Shanghai Chest Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Critical Care Medicine and Emergency, Shanghai Chest Hospital, Shanghai Jiao Tong University School of MedicineDepartmentof Clinical Medicine, First Clinical Medical College, Nanjing Medical UniversityDepartment of Critical Care Medicine and Emergency, Shanghai Chest Hospital, Shanghai Jiao Tong University School of MedicineAbstract Innate lymphoid cells (ILCs) are a class of lymphocytes that do not express specific antigen recognition receptors, which play a significant role in various diseases due to their unique immunomodulatory functions. Among these, type 2 innate lymphoid cells (ILC2s) form a distinct subpopulation and are recognized as key mediators in anti-infective and allergic responses. Cardiovascular diseases are a leading cause of intensive care unit admissions. Cardiovascular diseases, including myocardial infarction and heart failure, have a complex pathogenesis involving inflammation, tissue injury, and repair. Recent studies suggest that ILC2s are crucial in cardiovascular diseases by regulating inflammation, promoting tissue repair, and facilitating cardiac remodeling through the secretion of anti-inflammatory cytokines like IL-4, IL-5, and IL-13, etc. However, ILC2s have a complex role in cardiovascular health, potentially contributing to adverse cardiac remodeling and heart failure in certain contexts. Thus, the precise mechanisms by which ILC2s influence cardiovascular disease processes remain incompletely understood. This review summarizes recent advances in understanding ILC2 mechanisms in cardiovascular diseases and explores their potential as therapeutic targets, aiming to identify new treatment strategies.https://doi.org/10.1007/s44231-025-00078-xILC2Cardiovascular intensive careCytokinesMyocardial infarctionCardiac remodelingInflammation
spellingShingle Haibei Sun
Weizhuo Liu
Zelin Yu
Bin He
Type 2 Innate Lymphoid Cell in Cardiovascular Diseases: Complexities and Potentials
Intensive Care Research
ILC2
Cardiovascular intensive care
Cytokines
Myocardial infarction
Cardiac remodeling
Inflammation
title Type 2 Innate Lymphoid Cell in Cardiovascular Diseases: Complexities and Potentials
title_full Type 2 Innate Lymphoid Cell in Cardiovascular Diseases: Complexities and Potentials
title_fullStr Type 2 Innate Lymphoid Cell in Cardiovascular Diseases: Complexities and Potentials
title_full_unstemmed Type 2 Innate Lymphoid Cell in Cardiovascular Diseases: Complexities and Potentials
title_short Type 2 Innate Lymphoid Cell in Cardiovascular Diseases: Complexities and Potentials
title_sort type 2 innate lymphoid cell in cardiovascular diseases complexities and potentials
topic ILC2
Cardiovascular intensive care
Cytokines
Myocardial infarction
Cardiac remodeling
Inflammation
url https://doi.org/10.1007/s44231-025-00078-x
work_keys_str_mv AT haibeisun type2innatelymphoidcellincardiovasculardiseasescomplexitiesandpotentials
AT weizhuoliu type2innatelymphoidcellincardiovasculardiseasescomplexitiesandpotentials
AT zelinyu type2innatelymphoidcellincardiovasculardiseasescomplexitiesandpotentials
AT binhe type2innatelymphoidcellincardiovasculardiseasescomplexitiesandpotentials